Article
The treatment of established murine collagen-induced arthritis with a TNFR1-selective antagonistic mutant TNF.
Biomaterials - 1 Dec 2009
Shibata Hiroko, Yoshioka Yasuo, Abe Yasuhiro, Ohkawa Akiko, Nomura Tetsuya, Minowa Kyoko, Mukai Yohei, Nakagawa Shinsaku, Taniai Madoka, Ohta Tsunetaka, Kamada Haruhiko, Tsunoda Shin-ichi, Tsutsumi Yasuo
Abstract excerpt
Blocking the binding of TNF-alpha to TNF receptor subtype-1 (TNFR1) is an important strategy for the treatment of rheumatoid arthritis (RA). We recently succeeded in developing a TNFR1-selective antagonistic TNF mutant, R1antTNF. Here, we report the anti-inflammatory effects of R1antTNF in a murine collagen-induced arthritis model. To improve the in vivo stability of R1antTNF, we first engineered PEG...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
